Anadolu Medical Center
Anadolu Medical Center
Түркия, Істанбұл
Zafer Gulbas
49 жылдар тәжірибе • 3315+ емдеулер жасалған
аккредитациялар :
Аккредитация :
Түркияда лейкозды химиотерапиямен емдеу құны хаттаманың күрделілігі мен дәрі-дәрмек режиміне байланысты $8,000 – $16,000 аралығында болады. Жалпы шығынға диагностика кезеңі, стационарда болу ұзақтығы және науқастың жасы әсер етеді. Емдеу пакеттеріне әдетте онколог консультациясы, бастапқы қан талдаулары және химиотерапиялық препараттар кіреді.
Bookimed сарапшысының пікірі: АҚШ мекемелерімен серіктестігі бар клиникаларды таңдау Түркия бағасымен жоғары деңгейлі көмек алуға мүмкіндік береді. Мысалы, Анадолу медициналық орталығы Johns Hopkins Medicine-мен серіктес және соған ұқсас хаттамаларды қолданады. Ондағы жоғары деңгейлі пакеттер 50 000 $ жетсе де, JCI аккредитациясы бар Hisar Hospital сияқты орталықтар шамамен 12 000 $ көлемінде сапалы көмек ұсынады. Химиотерапия мақсаты өзгерген жағдайда емді үздіксіз жалғастыру үшін науқастарға сүйек кемігін трансплантациялау бөлімі бар орталықтарды таңдаған жөн.
Неліктен лейкемияға арналған химиотерапия үшін Түркияны таңдау қажет?
сенімді клиникаларда лейкемияға арналған химиотерапияның озық шешімдеріне қол жеткізіңіз.
| Түркия | Австрия | Испания | |
| Лейкоз кезіндегі химиотерапия | бастап $8,000 | бастап $15,000 | бастап $20,000 |
1 күн
2 күн
3 күн
4 күн - 10 күн (Емдеу күндері)
11 күн - 14 күн (емдеуден кейін)
2 апта - 4 апта (реабилитация)
Әр пациенттің қалпына келу мерзімі жеке жағдайларына және аурудың ауырлығына байланысты өзгеруі мүмкін екенін ескеріңіз.
Науқастарға не ұнайды:
Науқастарға не ұнамайды:
Профессор Зафер Гүлбаш — гематолог-онколог, Еуропадағы ең ірі орталықтардың бірі болып табылатын Anadolu Медициналық Орталығының Сүйек Миын Трансплантациялау Орталығының негізін қалаушы және директоры.
Науқастар неліктен доктор Гүлбашты таңдайды және оған сенеді:
Д-р Эда Танрыкулу «Анадолу» медициналық орталығында лейкемия химиотерапиясына маманданған, медициналық онкология саласында кең ауқымды дайындық пен тәжірибеге ие.
Мэйо Клиникасында дайындалған – доктор Севиндик Флоренс Найтингейл ауруханасына озық гематологиялық тәжірибені әкеледі.
Профессор Бюлент Эсердің гематология саласында 29 жылдық тәжірибесі бар, Medical Park Antalya клиникасында лейкемияны емдеуге маманданған.
Leukemia treatment success rates in Turkey often exceed 80% to 90% in specialized centers. Factors like cytogenetics and patient age influence outcomes. Childhood Acute Lymphoblastic Leukemia reaches a 90% 5-year survival rate, while adult Chronic Myeloid Leukemia shows 89.1% survival over 10 years.
Bookimed Expert Insight: Success rates in Turkey are high because top hematologists, such as Dr. Necdet Uskent at Anadolu Medical Center, follow Johns Hopkins Hospital protocols. Many Turkish specialists are US-trained and maintain high-volume practices. Dr. Zafer Gulbas reports an 81% success rate for autologous transplants alone, which is a key benchmark for international quality.
Patient Consensus: Patients value the 40–60% lower costs but emphasize the need for long-term follow-up care plans. Coordination between Turkish doctors and home-country physicians is essential for lasting remission.
The best hospitals for leukemia treatment in Turkey include Anadolu Medical Center, Memorial Şişli Hospital, and Medipol Mega University Hospital. These JCI-accredited facilities offer advanced therapies like bone marrow transplants and chemotherapy, often through partnerships with elite institutions like Johns Hopkins Medicine to ensure North American clinical standards.
Bookimed Expert Insight: While hospital reputation matters, the surgeon experience is the true differentiator in Turkey. Dr. Zafer Gulbas at Anadolu has personally performed over 3,000 transplants since 2010. This high volume often results in better management of post-chemotherapy complications compared to lower-volume centers.
Patient Consensus: Patients emphasize the importance of English-speaking staff and suggest hiring independent advocates for complex cases. Many recommend university hospitals like Hacettepe for exceptionally difficult leukemia diagnoses despite longer wait times.
Leukemia chemotherapy in Turkey utilizes international protocols like 7+3 for AML and hyper-CVAD or CALGB for ALL. These regimens include induction to achieve remission, consolidation to eliminate remaining cells, and maintenance. Clinics like Anadolu Medical Center follow Johns Hopkins Medicine standards using advanced targeted therapies.
Bookimed Expert Insight: While 7+3 is the global standard for AML, Turkish centers like Anadolu Medical Center often integrate rapid flow-cytometry diagnostics to adjust dosages mid-cycle. This data-driven approach, overseen by experts like Professor Zafer Gulbas, allows for highly personalized intensification cycles that may reduce overall hospital stay durations compared to fixed-schedule protocols.
Patient Consensus: Patients emphasize confirming intrathecal methotrexate scheduling early for CNS protection. Many noted that accessing targeted oral therapies like BTK inhibitors was significantly more affordable than in the US while maintaining identical clinical standards.
Leukemia chemotherapy in Turkey typically spans 6 to 12 months for acute conditions like AML or ALL. Treatment begins with a 4-week inpatient induction phase. This is followed by consolidation and maintenance cycles that can extend the total process up to 2 years.
Bookimed Expert Insight: Turkish oncology centers like Anadolu Medical Center provide exceptionally fast diagnostic-to-treatment transitions. While Western systems may involve months of waiting, our data shows patients start chemo within days. This speed is critical for acute leukemia where every day affects the success rate.
Patient Consensus: Many find the process faster than in their home countries. They suggest budgeting an extra 2 months for travel delays caused by infection or monitoring needs.
Yes, major Turkish hospitals have English-speaking haematologists and oncologists providing leukaemia chemotherapy. Clinics like Anadolu Medical Center, Memorial Şişli, and Hisar Hospital offer expert care with international standards and personal interpreters.
Bookimed Expert Insight: Many top Turkish hospitals like Anadolu and Memorial integrate English-speaking coordinators with highly experienced doctors such as Prof. Zafer Gulbas, who has performed 3,300+ bone marrow transplants. Personal translators are standard, which benefits Australian patients concerned about communication during complex treatments.
Patient Consensus: English-speaking doctors and translators helped patients feel comfortable during treatment in Turkey. Many Australians stay nearby hospitals with arranged transport and accommodation for chemo cycles every 3 weeks. Patients advise confirming language support early for a smooth experience.
Bone marrow transplantation (BMT) for leukaemia is widely available in Turkey, with leading hospitals like Anadolu Medical Center offering autologous and allogeneic transplants. These centres hold Joint Commission International (JCI) accreditations and show strong survival rates after 100 days post-transplant without complications.
Bookimed Expert Insight: Some centres in Istanbul combine transplantation with immunotherapy and CAR T-cell therapy. Anadolu Medical Center’s collaboration with Johns Hopkins Medicine ensures strong international standards. Packages often include airport transfers and personalised assistance, which matters for patients travelling from Australia.
Patient Consensus: Patients praise Turkey’s access to 9/10 HLA donor matches and smooth care coordination. Those from countries lacking BMT options find Turkey’s treatment comprehensive and well organised, with clear communication and reliable follow-up after discharge.
Top clinics for leukaemia chemotherapy in Turkey include Anadolu Medical Center and Memorial Şişli Hospital. These JCI-accredited centres offer advanced bone marrow transplants, personalised chemotherapy, and English-speaking staff. They provide trusted care for Australian patients alongside comprehensive patient support services.
Bookimed Expert Insight: Anadolu Medical Center’s Bone Marrow Transplant Director Dr Zafer Gulbas has supervised over 3,000 successful transplants, reflecting Turkey’s focus on high-experience specialists for leukaemia. Clinics with JCI accreditation and English coordinators, like Liv Hospital, better meet Australian patients’ communication and quality expectations.
Patient Consensus: Australian patients rarely choose Turkey given need for specialised long-term care. Those considering treatment value clear English communication and strong follow-up support, both available at Turkey’s top centres. Patients often advise consulting Australian oncologists before seeking overseas care.
Seeking leukaemia chemotherapy in Turkey starts with remote consultations and medical record reviews by expert haematologists. Leading clinics like Anadolu Medical Center and Hisar Hospital provide personalised plans including aggressive multi-regimen chemotherapy, targeted therapies, and stem cell transplants.
Bookimed Expert Insight: In Turkey, international patients often combine weekend trips with 2–3 day chemo cycles to cut accommodation costs. Clinics like Anadolu Medical Center use aggressive, customised chemotherapy protocols, leveraging their JCI accreditation and Johns Hopkins affiliation for high care standards. Istanbul hospitals lead in patient volume and offer excellent language support.
Patient Consensus: Patients say Turkish hospitals handle communication and transfers well, easing travel stress. Many recommend getting an online second opinion before booking. Treatment is intense but concise, allowing quick returns home with proper follow-up. Australian patients appreciate clear cost info and local support services.